跳至主要内容
临床试验/NCT06593405
NCT06593405招募中早期 1 期

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, Diabetic Retinopathy (DR) and Glaucoma

MCPHS University2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年4月22日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
招募中
发起方
入组人数
50
试验地点
2
主要终点
Revised Self Report Assessment of Functional Visual

研究概览

简要总结

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:

Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?

Participants will:

Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

详细描述

Many clients with low vision are unaware of OT, or the services OT can provide to assist with low vision needs. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills. Clients will complete the MediCog and the Revised-Self-Report Assessment of Functional Visual Performance (R-SRAFVP) assessment tools with the assistance of the OT. These tools will inform the therapist to areas of client needs and allow for focus on intervention to support these challenges. Follow up in OT 4 weeks post intervention will allow therapist to reassess the effectiveness of interventions provided via a phone or in-person interview as well as provide the assessments again. Second set of data from these assessments will be compared to initial findings obtained.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clients with AMD, DR or Glaucoma
  • Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.

排除标准

  • Clients with other age related eye diseases other than AMD, DR or Glaucoma.
  • Clients who do not wish to participate in this study.

研究组 & 干预措施

Receiving OT interventions

Experimental

All participants will receive all OT interventions

干预措施: occupational therapy interventions for low vision care (Combination Product)

结局指标

主要结局

Revised Self Report Assessment of Functional Visual

时间窗: Results from the Revised-Self-Report Assessment of Functional Visual Performance assessment will be determined on day 1 and 4 weeks later

A standardized assessment which provides information on how well adults with vision loss can perform daily tasks. This tool has 33 assessment components and a higher score indicates less functional impairment. A lower score indicates a higher impairment.

MediCog Screening Tool

时间窗: Results from the MediCog will be determined on day 1 and will be obtained 4 weeks later

The Medi-Cog has a maximum score of 10 points, and a score of 7 or lower may indicate cognitive impairment.

次要结局

未报告次要终点

研究者

发起方
MCPHS University
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验